About Celon Pharma
Celon Pharma is a publicly listed company based in Lomianki (Poland) founded in 2002 by Maciej Wieczorek. Generic and innovative medicinal products are developed and manufactured. The company has 558 employees. Its website celonpharma.com draws about 14 thousand monthly visits. Celon Pharma offers products and services including Generic Drugs. Its focus areas include Diversified Pharmaceuticals and Drugs. Its legal entity is Celon Pharma S.A.
Company details
Celon Pharma was founded in 2002 in Lomianki, Poland, where generic and innovative drugs are developed and manufactured in the pharmaceutical sector. Two fully equipped laboratories support research for both generic and innovative products, while production facilities hold GMP authorizations. The portfolio encompasses standard generics, drug combinations, and new drug designs, including potential innovations.
- Headquarters Lomianki, Poland
- Employees 558
- Founders Maciej Wieczorek
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website celonpharma.com
- Social LinkedIn
- Legal Name Celon Pharma Sa
- Annual Revenue$58.4 M (USD)16.71as on Dec 31, 2025
- Net Profit-$22.09 M (USD)-130.39as on Dec 31, 2025
- EBITDA-$2.92 M (USD)62.29as on Dec 31, 2025
- Employee Count558
Products & Services of Celon Pharma
Celon Pharma offers a comprehensive portfolio of products and services, including Generic Drugs.
Affordable generic medications for various patient treatments.
People of Celon Pharma
1 people are tracked at Celon Pharma (1 in leadership); the tracked headcount is 558.
| Name | Role | Group |
|---|---|---|
Maciej Wieczorek | Founder & President | Leadership |
Complete people profiles for Celon Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Celon Pharma
Celon Pharma is a publicly listed company on the GPW with ticker symbol CLN in Poland, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date16 Feb 2017
- Listed onWSE: CLN
- Listed entityCelon Pharma SA
- Exchange sectorHealth technology
- ISINPLCLNPH00015
- Share price18.96 PLN (+0.42% on the day) · 2026-10-14
- Market capitalisation1,017,849,056.00 PLN
- Price to earnings9.3
- EPS (diluted, trailing year)2.05 PLN
- Volume (last session)887
Financials of Celon Pharma
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 209.8M PLN | -79.4M PLN | -10.5M PLN |
| 2024 | 179.8M PLN | -34.5M PLN | -27.8M PLN |
| 2023 | 167.0M PLN | -28.1M PLN | -26.8M PLN |
| 2022 | 162.6M PLN | -39.3M PLN | -25.7M PLN |
| 2021 | 172.6M PLN | -11.6M PLN | 6.2M PLN |
Detailed financial statements for Celon Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Celon Pharma
The website of Celon Pharma (celonpharma.com) receives about 14K visits a month and ranks #2,315,042 among all websites worldwide, #3,166 in Biotechnology and Pharmaceuticals.
- Monthly visits14K
▲ 33.5% vs previous month
- Unique visitors3.4K
per month
- Global rank#2,315,042
among all websites
- Category rank#3,166
Health · Biotechnology and Pharmaceuticals
- Bounce rate50%
- Pages per visit2.1
- Average visit56 sec
- DevicesDesktop 25% · Mobile 75%
Websites whose visitors overlap most with Celon Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| celonlabs.com | 100% | 1.2K | #10,181,864 | View details | |
| swissmed.com.pl | 58% | View details | |||
pfs.gr | pfs.gr | 54% | #1,219,970 | – | |
| oktal-pharma.hr | 54% | 30.9K | #939,210 | View details | |
flamigel.be | flamigel.be | 54% | #3,221,691 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Celon Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Celon Pharma
Complete news archive for Celon Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Celon Pharma
Celon Pharma was founded in 2002.
Celon Pharma is headquartered in Lomianki, Poland. It is registered at Lomianki, Masovian Voivodeship, Poland.
Celon Pharma has 558 employees.
Annual revenue of Celon Pharma is $58.4M as on Dec 31, 2025.
Celon Pharma was founded in 2002 in Lomianki, Poland, where generic and innovative drugs are developed and manufactured in the pharmaceutical sector. Two fully equipped laboratories support research for both generic and innovative products, while production facilities hold GMP authorizations. The portfolio encompasses standard generics, drug combinations, and new drug designs, including potential innovations.
Celon Pharma offers Generic Drugs.
Yes, Celon Pharma is publicly traded on GPW under the ticker symbol CLN.
Celon Pharma operates through Celon Pharma S.A..